PortfoliosLab logoPortfoliosLab logo
EWTX vs. VICR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EWTX vs. VICR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edgewise Therapeutics Inc (EWTX) and Vicor Corporation (VICR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EWTX achieves a 54.87% return, which is significantly lower than VICR's 89.21% return.


EWTX

1D
-6.54%
1M
-2.86%
6M
36.52%
YTD
54.87%
1Y
168.55%
3Y*
75.99%
5Y*
17.02%
10Y*
ALL TIME*
6.82%

VICR

1D
0.34%
1M
-26.71%
6M
31.52%
YTD
89.21%
1Y
372.96%
3Y*
33.07%
5Y*
12.40%
10Y*
35.20%
ALL TIME*
7.83%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$33.88M$41.81M$53.57M
$233.23M$213.12M$256.68M

EWTX vs. VICR - Yearly Performance Comparison


2026 (YTD)20252024202320222021
EWTX
Edgewise Therapeutics Inc
54.87%-7.06%144.06%22.37%-41.49%-43.41%
VICR
Vicor Corporation
89.21%126.82%7.52%-16.39%-57.67%53.08%

Correlation

The correlation between EWTX and VICR is 0.24, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.24

Correlation (3Y)
Balances recent behavior with more history.

0.22

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.25

Correlation (All Time)
Calculated using the full available price history since Mar 26, 2021

0.24

Fundamentals

Market Cap

EWTX:

$4.13B

VICR:

$9.40B

EPS

EWTX:

-$1.67

VICR:

$3.12

PB Ratio

EWTX:

8.35

VICR:

11.86

Total Revenue (TTM)

EWTX:

$0.00

VICR:

$474.01M

Gross Profit (TTM)

EWTX:

$0.00

VICR:

$268.42M

EBITDA (TTM)

EWTX:

-$188.16M

VICR:

$127.59M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EWTX vs. VICR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

EWTX
EWTX Risk / Return Rank: 9494
Overall Rank
EWTX Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
EWTX Sortino Ratio Rank: 9393
Sortino Ratio Rank
EWTX Omega Ratio Rank: 9090
Omega Ratio Rank
EWTX Calmar Ratio Rank: 9898
Calmar Ratio Rank
EWTX Martin Ratio Rank: 9797
Martin Ratio Rank

VICR
VICR Risk / Return Rank: 9797
Overall Rank
VICR Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
VICR Sortino Ratio Rank: 9696
Sortino Ratio Rank
VICR Omega Ratio Rank: 9595
Omega Ratio Rank
VICR Calmar Ratio Rank: 9898
Calmar Ratio Rank
VICR Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

EWTX vs. VICR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Edgewise Therapeutics Inc (EWTX) and Vicor Corporation (VICR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EWTXVICRDifference
Sharpe ratioReturn per unit of total volatility

-1.85

Sortino ratioReturn per unit of downside risk

-0.47

Omega ratioGain probability vs. loss probability

1.36

1.48

-0.12

Calmar ratioReturn relative to maximum drawdown

8.12

7.12

+0.99

Martin ratioReturn relative to average drawdown

20.18

26.42

-6.24

EWTX vs. VICR - Sharpe Ratio Comparison

The current EWTX Sharpe Ratio is 2.23, which is lower than the VICR Sharpe Ratio of 4.08. The chart below compares the historical Sharpe Ratios of EWTX and VICR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EWTX vs. VICR - Drawdown Comparison

The maximum EWTX drawdown since its inception was -84.69%, smaller than the maximum VICR drawdown of -92.26%. Use the drawdown chart below to compare losses from any high point for EWTX and VICR.


Loading charts...

Drawdown Indicators


EWTXVICRDifference

Max Drawdown

Largest peak-to-trough decline

-84.69%

-92.26%

+7.57%

Max Drawdown (1Y)

Largest decline over 1 year

-21.01%

-51.88%

+30.87%

Max Drawdown (3Y)

Largest decline over 3 years

-68.81%

-59.25%

-9.56%

Max Drawdown (5Y)

Largest decline over 5 years

-75.41%

-80.47%

+5.06%

Max Drawdown (10Y)

Largest decline over 10 years

-80.47%

Current Drawdown

Current decline from peak

-20.52%

-45.40%

+24.88%

Average Drawdown

Average peak-to-trough decline

-52.43%

-58.31%

+5.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.43%

13.96%

-5.53%

Volatility

EWTX vs. VICR - Volatility Comparison

The current volatility for Edgewise Therapeutics Inc (EWTX) is 21.78%, while Vicor Corporation (VICR) has a volatility of 34.42%. This indicates that EWTX experiences smaller price fluctuations and is considered to be less risky than VICR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EWTXVICRDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.78%

34.42%

-12.64%

Volatility (6M)

Calculated over the trailing 6-month period

44.20%

75.16%

-30.96%

Volatility (1Y)

Calculated over the trailing 1-year period

76.46%

90.55%

-14.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

81.40%

74.65%

+6.75%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.93%

64.94%

+15.99%

Dividends

EWTX vs. VICR - Dividend Comparison

Neither EWTX nor VICR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

EWTX vs. VICR - Financials Comparison

This section allows you to compare key financial metrics between Edgewise Therapeutics Inc and Vicor Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


EWTX and VICR have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VICR has higher volatility (34.42%) compared to EWTX (21.78%). In terms of maximum drawdown, EWTX dropped -84.69% vs VICR's -92.26%.

VICR currently has the higher Sharpe Ratio (4.08 vs 2.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EWTX and VICR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer